• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

International Programs

  • Print
  • Share
  • E-mail

Global Engagement Initiatives

November 5, 2009

Excellency:

I would like to cordially invite you and/or senior representatives from your Embassy to a briefing and question and answer session by the U.S. Food and Drug Administration's Office of International Programs (FDA/OIP) on the Agency's global engagement. The meeting will be held on Tuesday, December 1,2009, from 2:00 p.m. to 5:00 p.m., at the Capital Hilton Hotel, 1001 16th Street, NW, The Federal A&B Room, Washington, DC 20036, 202-393-1000 (ww.hiltonsofdc.com/capitalhilton).

Recent increases in the global discovery, development and production of essentially all FDA-regulated products, and much of the clinical data supporting product authorization, require that FDA collaborate even more with its counterpart foreign regulatory authorities. This collaboration underpins FDA's domestic mission to protect and promote public health, and to help our counterpart regulatory authorities accomplish their domestic public health missions.

FDA is trying to engage more effectively with our foreign counterparts in many ways. As part of this engagement, we view our activities with embassies in Washington, DC as a critical part of any successful relationship. As you may be aware, to help meet our challenges, FDA established 13 posts around the globe over the past year, including posts in China, Europe, India and Latin America. We are also in the process of establishing posts in the Middle East.

At our briefing on the 1st of December, we will introduce our senior FDA/OlP officials who lead these offices, and provide information and answer questions you may have about FDA's global mission and the work of OIP.

We welcome your participation on December 1. Please RSVP by Wednesday, November 18, 2009, by contacting Antwionette Cobey in our office. She may be reached at 301-827-4480 or via e-mail at Antwionette.Cobey@fda.hhs.gov. For questions about the briefing, please contact Vashti Klein, Assistant Director for International Communications, Lop, at 301-827-0949 or Vashti.Klein@fda.hhs.gov.

More detailed information about the FDA's international posts is available on our website at: http://ww.fda.govlForConsumers/ConsumerUpdates/ucmI85769.htm.

We look forward to seeing you on December 1. Until then, please accept my warmest personal regards.

Sincerely yours,

---/s/---

Murray M. Lumpkin, M.D., M.Sc.
Deputy Commissioner
International Programs